March 30, 2020

Oxycodone Market Estimated to Exhibit 4.6% CAGR through 2018-2028


Oxycodone Market: Commercialization of Non-abuse Opioids Trending the Global Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028

Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028 — showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018–2019. Future Market Insights, in its recent analysis of the global oxycodone market, elaborates on the key market dynamics, opportunity assessment, and regional and competitive landscape analysis, for a period spanning 2018 to 2028.

With nearly 10-fold increase in the use of opioids since its inception, the oxycodone contributes to one of the largest revenue generator in the overall pharmaceutical landscape. Intensifying sales of oxycodone can be attributed to:

· Increasing patent expirations for branded products and much lesser new product launches, translating into increased consumption of generics — that contribute to the maximum revenue of the global oxycodone market, thereby, fueling the net sales.

· Growing number of cancer treatments, which in turn, increases the demand for supportive care medications for pain management. Increased prescriptions of oxycodone and Hydrocodone for treating cancer pain, will remain the largest contributor to the sales growth of the aforementioned medication.

We offer tailor-made solutions to fit your requirements, request customization@https://www.futuremarketinsights.com/customization-available/rep-gb-7638

“In terms of demand, high efficiency of synthetic and semi-synthetic opioids increase its use. In addition, Opioids prescription is highly regulated by a set of clinical practice guidelines, while ensuring safe access and proper dosage. Opioids are covered under such stringent regulations translates into increased consumption. Rising awareness about palliative care in terminal disease conditions combined with favorable reimbursement policies are some additional demand-side factors, augmenting the consumption of opioids”, projects a senior analyst at FMI

Elaborating further, the analyst explains that palliative care programs in US — which includes palliative care consultation teams and dedicated in-patient palliative care units — are delivered in accordance with the government and commercial reimbursement policies, further boosting the oxycodone market in the region. In addition to palliative programs, increased prescription in de-addiction programs, is well contributing to the demand of de-addiction opiates.

To know more about this market, request a sample@ https://www.futuremarketinsights.com/reports/sample/REP-GB-7638

Opportunity Analysis of Oxycodone Market Reveals Lucrative Growth Prospects

· In terms of business expansion opportunities, strategic investments, licensing agreements, and acquisitions hold significant potential.

· Apart from the above mentioned, investments in research and development activities would present potential growth opportunities for oxycodone manufacturers.

· Increasing strategic collaborations between manufacturers and generic drugs distributors operating in the pain management business, will prove critical to forward expansion plans.

· As demand for oxycodone remains uniform across patients of all age groups, opioids are expected to offer effective drug formulations and enhanced solubility of API, further prompting manufactures to capitalize on the emerging latent opportunity.

· Rising prevalence of chronic diseases in humans and increasing demand for parenteral formulations around the world, particularly in North American countries, will supplement to the growth of oxycodone market in the region.

Looking for a more in-depth analysis of the global oxycodone market? Feel free to connect with the team of expert analysts at [email protected]

About Healthcare division of FMI

The Healthcare team at Future Market Insights has consistently tracked and analyzed rapidly evolving trends and developments in the global healthcare industry, encompassing pharmaceuticals and medical devices markets. The team facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage.

Request for covid19 Impact Analysis @: https://www.futuremarketinsights.com/covid19/rep-gb-7638

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Mr. Abhishek Budholiya 616 Corporate Way, Suite 2–9018, Valley Cottage, NY 10989, United States T: +1–347–918–3531 F: +1–845–579–5705 T (UK): +44 (0) 20–7692–8790 Sales: [email protected] Press Office: [email protected] Blog: Market Research Blog Website: https://www.futuremarketinsights.com